Cargando…

EGFR Signaling in Lung Fibrosis

In this review article, we will first provide a brief overview of the ErbB receptor–ligand system and its importance in developmental and physiological processes. We will then review the literature regarding the role of ErbB receptors and their ligands in the maladaptive remodeling of lung tissue, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schramm, Fabian, Schaefer, Liliana, Wygrecka, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947373/ https://www.ncbi.nlm.nih.gov/pubmed/35326439 http://dx.doi.org/10.3390/cells11060986

Ejemplares similares

Targeting GLI Transcription Factors in Cancer
por: Didiasova, Miroslava, et al.
Publicado: (2018)

When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments
por: Didiasova, Miroslava, et al.
Publicado: (2019)

Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases
por: Zeng-Brouwers, Jinyang, et al.
Publicado: (2020)

The Role of Decorin and Biglycan Signaling in Tumorigenesis
por: Diehl, Valentina, et al.
Publicado: (2021)

EGFR signaling in renal fibrosis
por: Zhuang, Shougang, et al.
Publicado: (2014)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer
por: Rubio, Karla, et al.
Publicado: (2023)

CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis
por: Birnhuber, Anna, et al.
Publicado: (2020)

Transcriptional Profiling of Insulin-like Growth Factor Signaling Components in Embryonic Lung Development and Idiopathic Pulmonary Fibrosis
por: Kheirollahi, Vahid, et al.
Publicado: (2022)

Meprin β contributes to collagen deposition in lung fibrosis
por: Biasin, V., et al.
Publicado: (2017)

Human Lung Organoids—A Novel Experimental and Precision Medicine Approach
por: Kühl, Laura, et al.
Publicado: (2023)

From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer
por: Didiasova, Miroslava, et al.
Publicado: (2014)

The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology
por: Stolarczyk, Marta, et al.
Publicado: (2018)

EGFR-TKIs resistance via EGFR-independent signaling pathways
por: Liu, Qian, et al.
Publicado: (2018)

Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants
por: Hsieh, Louise Tzung-Harn, et al.
Publicado: (2017)

Protein Arginine Methyltransferases (PRMTs): Promising Targets for the Treatment of Pulmonary Disorders
por: Zakrzewicz, Dariusz, et al.
Publicado: (2012)

EGFR Signaling in Liver Diseases
por: Komposch, Karin, et al.
Publicado: (2015)

Arsenic Activates EGFR Pathway Signaling in the Lung
por: Andrew, Angeline S., et al.
Publicado: (2009)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
por: Suda, Kenichi, et al.
Publicado: (2021)

Understanding EGFR heterogeneity in lung cancer
por: Passaro, Antonio, et al.
Publicado: (2020)

EGFR Signaling in Colorectal Carcinoma
por: Krasinskas, Alyssa M.
Publicado: (2011)

EGFR Signaling: Friend or Foe for Cartilage?
por: Qin, Ling, et al.
Publicado: (2019)

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?
por: Ortiz-Zapater, Elena, et al.
Publicado: (2022)

Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond
por: Delaney, Christopher, et al.
Publicado: (2015)

Transgenic mice expressing a surfactant protein B–urokinase fusion protein in the distal respiratory epithelium are protected against acute lung injury and postinflammatory fibrosis
por: Markart, P, et al.
Publicado: (2007)

Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury
por: Wygrecka, Malgorzata, et al.
Publicado: (2022)

Germline EGFR mutations in lung cancer (Review)
por: Liu, Minghui, et al.
Publicado: (2023)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Updated Insights on EGFR Signaling Pathways in Glioma
por: Oprita, Alexandru, et al.
Publicado: (2021)

BIX01294 inhibits EGFR signaling in EGFR-mutant lung adenocarcinoma cells through a BCKDHA-mediated reduction in the EGFR level
por: Kim, Ji Hye, et al.
Publicado: (2021)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
por: Zhang, Zhe, et al.
Publicado: (2019)

The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
por: Saito, Akira, et al.
Publicado: (2018)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer
por: Morgillo, Floriana, et al.
Publicado: (2016)

Caveolin-1 Signaling in Lung Fibrosis
por: Tourkina, Elena, et al.
Publicado: (2012)

The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis
por: Venkataraman, Thiagarajan, et al.
Publicado: (2017)

Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis
por: Kadry, Yasmin A., et al.
Publicado: (2021)

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
por: Uribe, Mary Luz, et al.
Publicado: (2021)

Host-derived extracellular RNA promotes adhesion of Streptococcus pneumoniae to endothelial and epithelial cells
por: Zakrzewicz, Dariusz, et al.
Publicado: (2016)

EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment
por: Shiiya, Akihiko, et al.
Publicado: (2022)

Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
por: Makinoshima, Hideki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ie6f8ccodq7ridqm6vmeq6812r